Aclarion, Inc. (ACON) intrinsic value & 10-year financials

Aclarion, Inc. (ACON) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 6 fiscal years revenue grew 5.9% a year to $75.7K, with an average return on invested capital of -1213.6%.

Graham intrinsic value
—
Share price (Oct 17, 2026)
$1.85
Market cap
$984.3K
Revenue (FY2025)
$75.7K
Revenue growth (6-yr CAGR)
5.9%
ROIC (10-yr avg)
-1213.6%
Free cash flow (FY2025)
-$7.2M

ACON 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $75.7K -$7.2M -$13.61 -$7.2M -9312.5% -102.2%
FY2024 $45.7K -$7.0M -$13.26 -$5.3M -12057.2% -4555.1%
FY2023 $75.4K -$4.9M -$0.02 — -6466.5% -1548.2%
FY2022 $60.4K -$7.6M -$0.00 — -10089.5% 111.4%
FY2021 $60.3K -$5.0M -$0.00 — -4897.9% 26.2%
FY2020 — — — — — —

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

Aclarion, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.

Aclarion, Inc. has earned high returns on invested capital, averaging 40.7% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.

Aclarion, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, Aclarion, Inc. is modeled at 5.9% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-237.42 per share.

ACON stock: frequently asked questions

What is the intrinsic value of Aclarion, Inc. (ACON) stock?

Graham's formula only works with positive earnings. Aclarion, Inc. reported diluted EPS of -$13.61 in fiscal 2025, so no Graham value is shown. The 10-year table shows revenue and cash-flow trends instead.

Does Aclarion, Inc. generate free cash flow?

Aclarion, Inc. generated -$7.2M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 0 of the last 2 reported years.

What is ACON's return on invested capital?

Average ROIC over the last 6 fiscal years was -1213.6%, and average return on equity was -1324.4%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this ACON data come from?

From Aclarion, Inc.'s annual 10-K filings on SEC EDGAR, most recently filed Aug 6, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar medical laboratories stocks